Stocks to Watch: Pentair, Aehr Test Systems, Celcuity, Schmid Group

Dow Jones

15 hours ago

Pentair cut its revenue outlook for the year, citing declining pool sales, and said its chief financial officer had resigned. Shares slid 13% to $65.55 in after-hours trading on Tuesday.

Aehr Test Systems swung to a profit in its fiscal fourth quarter. The stock surged 27% to $91.56 after the bell.

Celcuity's breast cancer treatment, Revtorpyk, was approved by the Food and Drug Administration. Shares ran up in the last hour of Tuesday's session, closing up 7% at $11.05, before falling 5.5% to $105.00 after hours.

Schmid Group lifted its full-year order intake guidance. The stock gained 11% to $5.02 after hours.

Write to Elias Schisgall at elias.schisgall@wsj.com

(END) Dow Jones Newswires

July 14, 2026 19:12 ET (23:12 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2651348297"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2651348297\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2651348297?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-15 07:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651348297","market":"other","top_or_hot":-1,"title":"Stocks to Watch: Pentair, Aehr Test Systems, Celcuity, Schmid Group","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Pentair cut its revenue outlook for the year, citing declining pool sales, and said its chief financial officer had resigned. Shares slid 13% to $65.55 in after-hours trading on Tuesday. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/AEHR\">Aehr Test Systems</a> swung to a profit in its fiscal fourth quarter. The stock surged 27% to $91.56 after the bell. \n</p>\n<p>\n  Celcuity's breast cancer treatment, Revtorpyk, was approved by the Food and Drug Administration. Shares ran up in the last hour of Tuesday's session, closing up 7% at $11.05, before falling 5.5% to $105.00 after hours. \n</p>\n<p>\n  Schmid Group lifted its full-year order intake guidance. The stock gained 11% to $5.02 after hours. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 14, 2026 19:12 ET (23:12 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks to Watch: Pentair, Aehr Test Systems, Celcuity, Schmid Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks to Watch: Pentair, Aehr Test Systems, Celcuity, Schmid Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-15 07:12</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Pentair cut its revenue outlook for the year, citing declining pool sales, and said its chief financial officer had resigned. Shares slid 13% to $65.55 in after-hours trading on Tuesday. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/AEHR\">Aehr Test Systems</a> swung to a profit in its fiscal fourth quarter. The stock surged 27% to $91.56 after the bell. \n</p>\n<p>\n  Celcuity's breast cancer treatment, Revtorpyk, was approved by the Food and Drug Administration. Shares ran up in the last hour of Tuesday's session, closing up 7% at $11.05, before falling 5.5% to $105.00 after hours. \n</p>\n<p>\n  Schmid Group lifted its full-year order intake guidance. The stock gained 11% to $5.02 after hours. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 14, 2026 19:12 ET (23:12 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4161","symbol_name":"工业机械","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2651348297","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651348297","pubTimestamp":1784070720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Pentair cut its revenue outlook for the year, citing declining pool sales, and said its chief financial officer had resigned. Shares slid 13% to $65.55 in after-hours trading on Tuesday.Aehr Test Systems swung to a profit in its fiscal fourth quarter. The stock surged 27% to $91.56 after the bell.Celcuity's breast cancer treatment, Revtorpyk, was approved by the Food and Drug Administration. Shares ran up in the last hour of Tuesday's session, closing up 7% at $11.05, before falling 5.5% to $105.00 after hours.Schmid Group lifted its full-year order intake guidance. The stock gained 11% to $5.02 after hours.Write to Elias Schisgall at elias.schisgall@wsj.com Dow Jones NewswiresJuly 14, 2026 19:12 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4161":"工业机械","LU1596574779.USD":"BNP PARIBAS AQUA \"C\" (USDHDG) ACC","AQWA":"Global X Clean Water ETF","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU2125910179.SGD":"Natixis Thematics Water H-R/A SGD","BK4597":"股息贵族","BK4563":"昨日强势股","LU1543694498.USD":"法巴水资源基金RH MD Dis","BK4139":"生物科技","SHMD":"SCHMID GROUP N.V.","LU2125910336.SGD":"Natixis Thematics Water R/A SGD","LU1620156130.USD":"BNP PARIBAS AQUA \"C\" (USD) ACC","LU1892829315.USD":"FIDELITY FUNDS SUSTAINABLE WATER & WASTE \"A\" (USD) ACC","LU2506952337.HKD":"BNP PARIBAS CLIMATE IMPACT \"CRH\" (HKDHDG) ACC","LU2089279066.USD":"ALLIANZ GLOBAL WATER \"AT\" (USD) ACC","LU1923621640.USD":"Natixis Thematics Water R/A USD","BK4588":"碎股","LU1721428347.USD":"BNP PARIBAS CLIMATE IMPACT \"C\" (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU2477742899.HKD":"BNP PARIBAS CLIMATE IMPACT \"C\" (HKD) ACC","PNR":"滨特尔","LU2506952410.USD":"BNP PARIBAS CLIMATE IMPACT \"CRH\" (USDHDG) ACC A","LU1917777945.USD":"安联专题基金Cl AT Acc","AEHR":"Aehr Test Systems","LU2229751404.USD":"ALLIANZ GLOBAL WATER \"AT3\" (USD) ACC","LU2413665964.HKD":"BNP PARIBAS AQUA \"C\" (HKD) ACC","LU1989763690.USD":"东方汇理世代食品基金A2 Acc","LU2240825500.USD":"AZ EQUITY - WATER & RENEWABLE RESOURCES \"A-AZ\" (USD) ACC","BK4147":"半导体设备","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","CELC":"Celcuity Inc","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","LU1620156213.USD":"BNP PARIBAS AQUA \"C\" (USD) INC","LU1989763427.SGD":"CPR Invest - Food For Generations A2 Acc SGD-H","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1165135440.EUR":"BNP Paribas Aqua Classic Cap EUR","BK4585":"ETF&股票定投概念","BK4145":"电子制造服务","LU2413666004.HKD":"BNP PARIBAS AQUA \"CRH\" (HKDHDG) INC","LU1721427968.SGD":"BNP PARIBAS AQUA \"CRH\" (SGDHDG) INC"},"translate_title":"值得关注的股票：Pentair、Aehr Test Systems、Celcuity、Schmid Group","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SHMD":0.9,"PNR":0.9,"AEHR":1.5,"AQWA":0.6,"CELC":0.9},"content_text":"Pentair cut its revenue outlook for the year, citing declining pool sales, and said its chief financial officer had resigned. Shares slid 13% to $65.55 in after-hours trading on Tuesday. \n\n\nAehr Test Systems swung to a profit in its fiscal fourth quarter. The stock surged 27% to $91.56 after the bell. \n\n\n  Celcuity's breast cancer treatment, Revtorpyk, was approved by the Food and Drug Administration. Shares ran up in the last hour of Tuesday's session, closing up 7% at $11.05, before falling 5.5% to $105.00 after hours. \n\n\n  Schmid Group lifted its full-year order intake guidance. The stock gained 11% to $5.02 after hours. \n\n\n \n\n\n  Write to Elias Schisgall at elias.schisgall@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 14, 2026 19:12 ET (23:12 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}